Abstract
Generalized convulsive status epilepticus (GCSE) represents the most clinically dramatic and life-threatening type of status epilepticus, characterized either by continuous generalized tonic–clonic convulsive seizures or by repetitive bilateral convulsive seizures without recovery to functional baseline in the interictal periods. Although GCSE can emerge from partial seizures or partial status epilepticus, and the convulsions typically decrease by frequency and intensity over time, the widespread clonic movements represent the pathognomonic clinical feature of GCSE. Despite highly advanced neurointensive care, complications and mortality of GCSE remain high. An understanding of the underlying causes, the clinical manifestations, and the immediate systemic and neurologic consequences of GCSE are keys for optimal treatment. This chapter will discuss the epidemiology, classification, and etiologies of GCSE in adults along with acute systemic and neurologic consequences, and recommendations for optimal neurointensive care.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46(4):1029–35.
DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33(Suppl 4):15–25.
Barry E, Hauser WA. Status epilepticus: the interaction of epilepsy and acute brain disease. Neurology. 1993;43(8):1473–8.
Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67(8):931–40.
Vignatelli L, Tonon C, D’Alessandro R. Bologna Group for the study of status epilepticus. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia. 2003;44(7):964–8.
Wu YW, Shek DW, Garcia PA, Zhao S, Johnston SC. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58(7):1070–6.
Boggs JG, Painter JA, DeLorenzo RJ. Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res. 1993;14(1):87–94.
Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41(Suppl 2):23–30.
Delanty N, French JA, Labar DR, Pedley TA, Rowan AJ. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure. 2001;10(2):116–9.
Hocker S. Systemic complications of status epilepticus—an update. Epilepsy Behav. 2015;49:83–7.
Schmutzhard E, Pfausler B. Complications of the management of status epilepticus in the intensive care unit. Epilepsia. 2011;52(Suppl 8):39–41.
Rudin D, Grize L, Schindler C, Marsch S, Rüegg S, Sutter R. High prevalence of nonconvulsive and subtle status epilepticus in an ICU of a tertiary care center: a three-year observational cohort study. Epilepsy Res. 2011;96(1–2):140–50.
Sutter R, Marsch S, Fuhr P, Rüegg S. Mortality and recovery from refractory status epilepticus in the ICU: a 7-year observational study. Epilepsia. 2013;54(3):502–11.
Sutter R, Kaplan PW, Rüegg S. Outcome predictors for status epilepticus—what really counts. Nat Rev Neurol. 2013;9(9):525–34.
Vooturi S, Jayalakshmi S, Sahu S, Mohandas S. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit. Clin Neurol Neurosurg. 2014;126:7–10.
Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia. 1994;35(5):1104–12.
Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology. 2007;69(9):886–93.
Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of status epilepticus in adults. Neurology. 2006;66(11):1736–8.
Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561–6.
Kortland LM, Knake S, Rosenow F, Strzelczyk A. Cost of status epilepticus: A systematic review. Seizure. 2015;24C:17–20.
Misra UK, Kalita J, Bhoi SK, Dubey D. Cost of status epilepticus in a tertiary care hospital in India. Seizure. 2015;31:94–8.
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Neurocritical care society status epilepticus guideline writing committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.
Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol. 1995;12(4):343–62.
Treiman DM, DeGiorgio CMA, Salisbury SM, Wickboldt CL. Subtle generalized convulsive status epilepticus. Epilepsia. 1984;25:653.
Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M. Neurointensive care section of the European Society of intensive care medicine. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39(8):1337–51.
Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. J Clin Neurophysiol. 2004;21(5):319–31.
Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 1990;5(1):49–60.
Garzon E, Fernandes RM, Sakamoto AC. Serial EEG during human status epilepticus: evidence for PLEDs as an ictal pattern. Neurology. 2001;57(7):1175–83.
Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology. 1992;42(1):100–4.
Nei M, Lee JM, Shanker VL, Sperling MR. The EEG and prognosis in status epilepticus. Epilepsia. 1999;40(2):157–63.
Guidelines for epidemiologic studies on epilepsy. Commission on epidemiology and prognosis, international league against epilepsy. Epilepsia. 1993;34(4):592–6.
Celesia GG. Modern concepts of status epilepticus. JAMA. 1976;235(15):1571–4.
Obeso JA, Rothwell JC, Marsden CD. The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain. 1985;108(Pt 1):193–24.
Sutter R, Ristic A, Rüegg S, Fuhr P. Myoclonus in the critically ill: diagnosis, management, and clinical impact. Clin Neurophysiol. 2016;127(1):67–80.
Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia. 2001;42(4):515–24.
Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657–66.
Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43(3):483–8.
Velioğlu SK, Ozmenoğlu M, Boz C, Alioğlu Z. Status epilepticus after stroke. Stroke. 2001;32(5):1169–72.
Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001;57(2):200–6.
DeLorenzo RJ, Kirmani B, Deshpande LS, Jakkampudi V, Towne AR, Waterhouse, et al. Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virginia. Seizure. 2009;18(6):405–11.
Afsar N, Kaya D, Aktan S, Sykut-Bingol C. Stroke and status epilepticus: stroke type, type of status epilepticus, and prognosis. Seizure. 2003;12(1):23–7.
Bateman BT, Claassen J, Willey JZ, Hirsch LJ, Mayer SA, Sacco RL, Schumacher HC. Convulsive status epilepticus after ischemic stroke and intracerebral hemorrhage: frequency, predictors, and impact on outcome in a large administrative dataset. Neurocrit Care. 2007;7(3):187–93.
Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52(11):1273–6.
De Reuck J, Hemelsoet D, Van Maele G. Seizures and epilepsy in patients with a spontaneous intracerebral haematoma. Clin Neurol Neurosurg. 2007;109(6):501–4.
Procaccianti G, Zaniboni A, Rondelli F, Crisci M, Sacquegna T. Seizures in acute stroke: incidence, risk factors and prognosis. Neuroepidemiology. 2012;39(1):45–50.
Ferro JM, Pinto F. Poststroke epilepsy: epidemiology, pathophysiology and management. Drugs Aging. 2004;21(10):639–53.
Alberti A, Paciaroni M, Caso V, Venti M, Palmerini F, Agnelli G. Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag. 2008;4(3):715–20.
Passero S, Rocchi R, Rossi S, Ulivelli M, Gatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43(10):1175–80.
Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617–22.
Reith J, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen stroke study. Stroke. 1997;28(8):1585–9.
De Herdt V, Dumont F, Hénon H, Derambure P, Vonck K, Leys D, Cordonnier C. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77(20):1794–800.
Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol. 1995;52(7):717–24.
Goonawardena J, Marshman LA, Drummond KJ. Brain tumour-associated status epilepticus. J Clin Neurosci. 2015;22(1):29–34.
DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):316–25.
Hauser WA. Status epilepticus: epidemiologic considerations. Neurology. 1990;40(5 Suppl 2):9–13.
Annegers JF, Coan SP. The risks of epilepsy after traumatic brain injury. Seizure. 2000;9(7):453–7.
Annegers JF, Grabow JD, Groover RV, Laws ER Jr, Elveback LR, Kurland LT. Seizures after head trauma: a population study. Neurology. 1980;30(7 Pt 1):683–9.
Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338(1):20–4.
Schierhout G, Roberts I. Prophylactic antiepileptic agents after head injury: a systematic review. J Neurol Neurosurg Psychiatry. 1998;64(1):108–12.
Chang BS, Lowenstein DH, Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;60(1):10–6.
Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35(1):27–34.
Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146–53.
Logroscino G, Castaneda DC, Cascino G, Hauser WA. Status epilepticus without an underlying cause and risk of death: a population-based study. Arch Neurol. 2008;65(2):221–4.
Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45(7):757–63.
Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia. 2007;48(4):732–42.
Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14(12):1377–83.
Janigro D. Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier. Epilepsia. 2012;53(Suppl 1):26–34.
Bauer S, Köller M, Cepok S, Todorova-Rudolph A, Nowak M, Nockher WA, et al. NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy. Exp Neurol. 2008;211(2):370–7.
Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96(Pt A):70–82.
Heinemann U, Kaufer D, Friedman A. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia. 2012;60(8):1251–7.
Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2(10):734–44.
Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J Neuroimmune Pharmacol. 2012;7(1):42–59.
Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):31–40.
Viviani B, Gardoni F, Marinovich M. Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol. 2007;82:247–63.
Chen WB, Gao R, Su YY, Zhao JW, Zhang YZ, Wang L, et al. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Eur J Neurol. 2011;18(12):1391–6.
Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, et al. Seizures in multiple sclerosis. Epilepsia. 2001;42(1):72–9.
Nyquist PA, Cascino GD, Rodriguez M. Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990–1998. Mayo Clin Proc. 2001;76(10):983–6.
Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276–86.
Gaspard N, Foreman BP, Alvarez V, Carbrera Kang C, Probasco JC, Jongeling AC, Critical Care EEG Monitoring Research Consortium (CCEMRC), et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85(18):1604–13.
Leach JP, Mohanraj R, Borland W. Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention. Epilepsia. 2012;53(Suppl 4):48–57.
Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia. 1993;34(6):1033–7.
Fernandez-Torre JL, Kaplan PW. Subacute encephalopathy with seizures in alcoholics (SESA syndrome) revisited. Seizure. 2014;23(5):393–6.
Hillbom M, Pieninkeroinen I, Leone M. Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs. 2003;17(14):1013–30.
Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology. 1989;39(8):1037–9.
Sutter R, Rüegg S, Kaplan PW. Epidemiology, diagnosis, and management of nonconvulsive status epilepticus—opening Pandora’s box. Neurology Clin Pract. 2012;2(3):275–86.
Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology. 1990;40(5 Suppl 2):23–7.
Trinka E, Hofler J, Zerbs A. Causes of status epilepticus. Epilepsia. 2012;53(Suppl 4):127–38.
Walton NY. Systemic effects of generalized convulsive status epilepticus. Epilepsia. 1993;34(Suppl 1):S54–8.
Belcour D, Jabot J, Gerard B, Roussiaux A, Ferdynus C, Vandroux D, Vignon P. Prevalence and risk factors of stress cardiomyopathy after convulsive status epilepticus in ICU patients. Crit Care Med. 2015;43(10):2164–70.
Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36(3):174–84.
Meldrum BS, Vigouroux RA, Brierley JB. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol. 1973;29(2):82–7.
Gorter JA, van Vliet EA, Aronica E. Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav. 2015;49:13–6.
Miskin C, Hasbani DM. Status epilepticus: immunologic and inflammatory mechanisms. Semin Pediatr Neurol. 2014;21(3):221–5.
Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69:16–24.
Janigro D, Iffland PH 2nd, Marchi N, Granata T. A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches. Epilepsia. 2013;54(Suppl 6):30–2.
Nevander G, Ingvar M, Auer R, Siesjö BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985;18(3):281–90.
Scharfman HE. Epilepsy as an example of neural plasticity. Neuroscientist. 2002;8(2):154–73.
Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28(1):10–7.
Meldrum BS, Brierley JB. Neuronal loss and gliosis in the hippocampus following repetitive epileptic seizures induced in adolescent baboons by allylglycine. Brain Res. 1972;48:361–5.
Corsellis JA, Bruton CJ. Neuropathology of status epilepticus in humans. Adv Neurol. 1983;34:129–39.
Nevander G, Ingvar M, Auer R, Siesjö BK. Irreversible neuronal damage after short periods of status epilepticus. Acta Physiol Scand. 1984;120(1):155–7.
DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia. 1992;33(1):23–7.
Tan LA, Byrne RW. Bilateral humeral fractures mimicking Todd’s paralysis. Br J Neurosurg. 2015;29(5):733.
Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):326–42.
Howse DC. Cerebral energy metabolism during experimental status epilepticus. Adv Neurol. 1983;34:209–16.
Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23(9):1261–76.
Hanhan UA, Fiallos MR, Orlowski JP. Status epilepticus. Pediatr Clin North Am. 2001;48(3):683–94.
Simon RP. Physiologic consequences of status epilepticus. Epilepsia. 1985;26(Suppl 1):S58–66.
Simon RP, Bayne LL, Tranbaugh RF, Lewis FR. Elevated pulmonary lymph flow and protein content during status epilepticus in sheep. J Appl Physiol Respir Environ Exerc Physiol. 1982;52(1):91–5.
Etsten B, Li TH. Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume. J Clin Invest. 1955;34(3):500–10.
Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37(12):3024–30.
Kowalski RG, Ziai WC, Rees RN, Werner JK Jr, Kim G, Goodwin H, Geocadin RG. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40(9):2677–84.
Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S. Anesthetic drugs in status epilepticus—risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656–64.
Marchi NA, Novy J, Faouzi M, Stähli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003–9.
Diaz JH, Prabhakar A, Urman RD, Kaye AD. Propofol infusion syndrome: a retrospective analysis at a level 1 trauma center. Crit Care Res Pract. 2014;2014:346968.
Singhal PC, Chugh KS, Gulati DR. Myoglobinuria and renal failure after status epilepticus. Neurology. 1978;28(2):200–1.
Sato T, Ota M, Matsuo M, Tasaki H, Miyazaki S. Recurrent reversible rhabdomyolysis associated with hyperthermia and status epilepticus. Acta Paediatr. 1995;84(9):1083–5.
Sutter R, Tschudin-Sutter S, Grize L, Fuhr P, Bonten MJ, Widmer AF, et al. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia. 2012;53(9):1489–97.
Zelano J, Möller F, Dobesberger J, Trinka E, Kumlien E. Infections in status epilepticus: a retrospective 5-year cohort study. Seizure. 2014;23(8):603–6.
Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keränen T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure. 2002;11(1):44–6.
Bauer S, Cepok S, Todorova-Rudolph A, Nowak M, Köller M, Lorenz R. Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 2009;86(1):82–8.
Sutter R, Tschudin-Sutter S, Grize L, Widmer AF, Marsch S, Rüegg S. Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus. Crit Care. 2011;15(6):R274.
Sutter R, Valenca M, Tschudin-Sutter S, Rüegg S, Marsch S. Procalcitonin and mortality in status epilepticus: an observational cohort study. Crit Care. 2015;19(1):361.
Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F, et al. Cytokines and epilepsy. Seizure. 2011;20(3):249–56.
Sutter R, Ruegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: a systematic review. Neurology. 2015;85(15):1332–41.
Sutter R, Kaplan PW. Can anesthetic treatment worsen outcome in status epilepticus? Epilepsy Behav. 2015;49:294–7.
Suchomelova L, Lopez-Meraz ML, Niquet J, Kubova H, Wasterlain CG. Hyperthermia aggravates status epilepticus-induced epileptogenesis and neuronal loss in immature rats. Neuroscience. 2015;305:209–24.
Rheims S, Ryvlin P. Patients’ safety in the epilepsy monitoring unit: time for revising practices. Curr Opin Neurol. 2014;27(2):213–8.
Buck D, Baker GA, Jacoby A, Smith DF, Chadwick DW. Patients’ experiences of injury as a result of epilepsy. Epilepsia. 1997;38(4):439–44.
Davidson DL, Macdonald S. The costs of trauma caused by seizures: can they be reduced? Seizure. 2002;11(5):344–7.
McCullen GM, Brown CC. Seizure-induced thoracic burst fractures. A case report. Spine (Phila Pa 1976). 1994;19(1):77–9.
Parrish GA, Skiendzielewski JJ. Bilateral posterior fracture-dislocations of the shoulder after convulsive status epilepticus. Ann Emerg Med. 1985;14(3):264–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Sutter, R., Dittrich, T.D., Kaplan, P.W. (2018). Causes, Manifestations, and Complications of Generalized Convulsive Status Epilepticus in Adults. In: Drislane, F., Kaplan MBBS, P. (eds) Status Epilepticus. Current Clinical Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-58200-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-58200-9_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58198-9
Online ISBN: 978-3-319-58200-9
eBook Packages: MedicineMedicine (R0)